In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
Ruchira Kamboj has taken over as the new Permanent Representative of India to the United Nations.
Congress' Bharat Jodo Nyay Yatra led by Rahul Gandhi proceeded from Dhubri in Assam on Thursday.
US President Donald Trump has imposed an additional 25% tax on goods coming from India. This tax
Rob Walter on Quinton De Kock's Retirement Decision: Before the upcoming series against India, So
The central government is in action mode regarding Cyclone Michong. Prime Minister Narendra Modi
Recently, PM Modi and Russian President Vladimir Putin met at the SCO meeting. In this meeting, t
The corona speed in the country is increasing at a record pace. More than 2 lakh 50 thousand case
A strange incident happened during the hearing of Bollywood actress Juhi Chawla's petition challe
After 15 days of the attack on Ukraine, now Russia's spirits have started to waver. Russia's army
Prime Minister Narendra Modi addressed young voters on National Voters' Day on Thursday. During t
